Effectiveness of Liraglutide and Lixisenatide in the Treatment of Type 2 Diabetes: Real-World Evidence from The Health Improvement Network (THIN) Database in the United Kingdom

Apr-17

Endocrinology Pharmacoepidemiology

AUTHORS : Gabriela Vega-Hernandez, Novo Nordisk, West Sussex, UK – Email: gvg@novonordisk.com

JOURNAL : Diabetes Therapy

REFERENCE: 8(2):417-431

DOI : 10.1007/s13300-017-0241-z

Read more